Structure |
Chemical Name |
CAS |
MF |
|
Alogliptin Impurity 17 |
|
|
|
Aprepitant Impurity 15 |
1447693-83-5 |
C20H19ClF7NO2 |
|
Betamethasone EP Impurity H |
185613-71-2 |
C22H29FO5 |
|
Blonanserin Impurity 10 |
132810-87-8 |
C23H30ClN3 |
|
Blonanserin impurity G |
|
|
|
Cefodizime Impurity 5 |
|
|
|
Clindamycin Impurity 4 |
|
|
|
Doxofylline Impurity 4 |
2095554-12-2 |
C11H16N4O5 |
|
Eltrombopag Impurity 1 |
1246929-02-1 |
C25H23N5O3 |
|
Everolimus impurity A |
|
|
|
Fosaprepitant Impurity 13 |
|
|
|
Gefitinib Impurity J |
|
|
|
Isavuconazole Impurity 23 |
|
|
|
Isavuconazole Impurity 29 |
|
|
|
Isavuconazole Impurity 7 |
|
|
|
Lercanidipine Impurity 6 |
786625-22-7 |
C37H43N3O6 |
|
Linagliptin Impurity 43 |
|
|
|
MiraBegron Impurity A |
|
|
|
Moxifloxacin Impurity 15 |
|
|
|
Moxifloxacin Impurity 32 |
|
|
|
Nifedipine Impurity F |
53055-15-5 |
C18H20N2O6 |
|
Olaparib Impurity 15 |
2250243-17-3 |
C24H25FN4O3 |
|
Olopatadine Impurity 4 |
55690-15-8 |
C18H18O5 |
|
Posaconazole Impurity 26 |
|
|
|
Posaconazole Impurity 48 |
1902954-03-3 |
C37H42F2N8O5 |
|
Posaconazole Impurity 9 |
|
|
|
Roxithromycin Impurity E |
|
|
|
SofosBuvir impurity 48 |
|
|
|
SofosBuvir Impurity 54 |
1431932-81-8 |
C12H17ClNO4P |
|
Timolol EP Impurity G |
75202-36-7 |
C6H9N3O3S |
|
Tofacitinib Impurity 44 |
2374700-39-5 |
C13H19N5 |
|
Trelagliptin Impurity 24 |
|
|
|
dimethyl 3- isobutylpentanedioate |
145328-03-6 |
C11H20O4 |
|
Phenol, 4-chloro-3-[(4-ethoxyphenyl)methyl]- |
1408077-50-8 |
C15H15ClO2 |
|
2-amino-9-((3aS,4S,6S,6aR)-3a,6-dihydroxyhexahydro-1H-cyclopenta[c]furan-4-yl)-1,9-dihydro-6H-purin-6-one |
1984788-96-6 |
C12H15N5O4 |
|
Ampicillin Impurity C |
|
|
|
Ampicillin Impurity O |
|
|
|
mixture of PD 312236 and PD 312237 |
|
|
|
Axitinib Impurity 27 |
1639137-80-6 |
C24H20N4O2S |
|
(4R,5R,6S)-4-nitrobenzyl 6-((R)-1-hydroxyethyl)-4-methyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate |
104873-15-6 |
C17H18N2O7 |
|
Lesinurad Impurity |
|
|
|
Chrysophanol triglucoside |
120181-07-9 |
C33H40O19 |
|
7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-(5-chloro-2-ethoxyphenyl)-1,6-dihydro-1-methyl-3-propyl- |
1829588-57-9 |
C17H19ClN4O2 |
|
Cefminox sodium impurities Ⅲ |
|
|
|
Canagliflozin Impurity 18 |
1951467-29-0 |
C24H25FO6S |
|
Fosaprepitant Impurity 6 |
327623-34-7 |
C21H19F6NO3 |
|
Ivabradine Impurity 16 HCl |
304464-98-0 |
C26H34N2O5 |
|
Moxifloxacin EP Impurity A HCl |
|
|
|
Paroxetine EP Impurity H HCl |
503834-41-1 |
C19H23ClFNO |
|
Solifenacin Related Compound 13 |
1251905-45-9 |
C17H17NO2 |
|
1-(3-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide |
2101651-50-5 |
C14H12FN5 |
|
N1-(4-chlorophenyl)-3,12-diimino-N14-phenyl-2,4,11,13-Tetraazatetradecanediimidamide |
152504-12-6 |
C22H31ClN10 |
|
Ethylmethyl-carbamic chloride |
42252-34-6 |
C4H8ClNO |
|
Cisatracurium-20-methyl Dibenzenesulfonate |
1193104-85-6 |
C60H79N2O15S+ |
|
Oxaliplatin impurity |
|
|
|
NiMesulide EP IMpurity |
38880-53-4 |
C7H8N2O5S |
|
Alogliptin Impurity D |
1926163-25-8 |
C61H86N16O13 |
|
Moxifloxacin Impurities |
|
|
|
Parecoxib Impurity K |
198471-69-1 |
C17H16N2O3S |
|
Linagliptin Impurity K |
1638744-06-5 |
C25H29BrN8O2 |
|
(R)-2-((6-(3-((3-(2-cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile |
1917324-13-0 |
C31H28F2N8O4 |
|
L-Phenylalanine, N-[(5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl)carbonyl]-3-(methylsulfonyl)-, phenylmethyl ester, hydrochloride (1:1) |
1194550-65-6 |
C27H27Cl3N2O5S |
|
Alogliptin Related Compound 23 |
1618644-29-3 |
C20H13ClN4O2 |
|
Etoricoxib Impurity 14 |
|
|
|
Riociguat Impurtiy 3 |
|
|
|
Trelagliptin Impurity 2 |
|
|
|
Chlorhexidine Impurity B |
1308292-89-8 |
C16H26ClN9O |
|
Dapoxetine Impurity D |
|
|
|
Eltrombopag Impurity 5 |
|
|
|
Exemestane Impurity 1 |
159354-61-7 |
C20H24O3 |
|
Iguratimod Impurity 9 |
1179354-65-4 |
C18H16N2O6S |
|
Lidocaine Impurity |
35891-84-0 |
C11H16N2O.ClH |
|
Pramipexole Impurity J |
|
|
|
Solifenacin Related Compound 14 |
605696-10-4 |
C25H30N2O2 |
|
4-amino-1-((2R,3R,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one |
160552-54-5 |
C8H11N3O4S |
|
1-(4-Hydroxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide |
503612-76-8 |
C24H23N5O4 |
|
8-[(1R)-1-Hydroxy-2-[[2-(4-methoxyphenyl)-1,1-dimethylethyl]amino]ethyl]-6-(phenylmethoxy)-2H-1,4-benzoxazin-3(4H)-one |
869478-13-7 |
C28H32N2O5 |
|
1-(2-(methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
743460-48-2 |
C21H27N3O2 |
|
Cefuroxime Sodium impurity D |
|
C16H16N4NaO8S |
|
Silodosin impurity A |
|
|
|
cefditoren △-3 isomer |
|
|
|
Ixazomib Impurity 1 |
1201903-02-7 |
C24H33BCl2N2O4 |
|
Ofloxacin/Levofloxacin Impurity E |
|
|
|
(3S)-9,10-difluoro-3-methyl-7-oxo-2,3,6,7-tetrahydro-5H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid |
1026952-91-9 |
C13H11F2NO4 |
|
((4-Methoxyphenoxy)methylene)dibenzene |
85686-16-4 |
C20H18O2 |
|
Tofacitinib Impurity L |
|
|
|
1-chloro-3-(dimethoxymethyl)benzene |
3395-80-0 |
C9H11ClO2 |
|
N-(3-bromo-4-oxocyclohexyl)acetamide |
687639-03-8 |
C8H12BrNO2 |
|
methyl (Z)-3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylate |
|
C44H51N9O4 |
|
Alvimopan Impurity 5 |
|
|
|
Palbociclib-d8 |
1628752-83-9 |
C24H21D8N7O2 |
|
Ivabradine Impurity 15 |
1132667-04-9 |
C12H17NO2 |
|
Sofosbuvir Impurity27 |
|
|
|
Isavuconazole Impurity 12 |
|
|
|
Tacrolimus Impurity 3 |
161861-10-5 |
C45H71NO13 |
|
Aprepitant EP Impurity C |
2208275-99-2 |
C29H25F7N4O3 |
|
[R-(R*,S*)]-(-)-N-(1-PHENYLETHYL)-1-AZABICYCLO[2.2.2]OCTAN-3-AMINE DIHYDROCHLORIDE |
128311-06-8 |
C15H24Cl2N2 |
|
GURKHSYORGJETM-MGDILKBHSA-N |
1992961-26-8 |
C33H39ClN4O6 |
|
DVCUGHHGLKCBMT-QVDQXJPCSA-N |
1356353-76-8 |
C15H24N6O6 |
|
5,6-Dehydro-Tigecycline |
1633815-62-9 |
C29H37N5O8 |